Stuart A. Lipton
Affiliations: | Scripps Research Institute, La Jolla, La Jolla, CA, United States | ||
| Neurosciences | University of California, San Diego, La Jolla, CA |
Area:
Neurodegenerative DiseaseWebsite:
https://www.scripps.edu/research/faculty/liptonGoogle:
"Stuart Lipton"Bio:
https://www.scripps.edu/lipton/members.html
Mean distance: 12.18 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| John E. Dowling | grad student | 1977 | Harvard |
| Torsten Wiesel | post-doc | Harvard Medical School |
Children
Sign in to add trainee| Jeffrey D. Zaremba | research assistant | 2007-2011 | Burnham Institute |
| Scott D. Ryan | post-doc | 2011- | Sanford Burnham Research Institute |
| Karthik Bodhinathan | post-doc | 2014- | Sanford-Burnham Medical Research Institute |
| Swagata Ghatak | post-doc | 2016- | |
| Elias Aizenman | post-doc | 1985-1987 | Harvard Medical School |
| Thomas Goetz | post-doc | 2000-2003 | Burnham Institute |
| Walid V. Soussou | post-doc | 2006-2008 | Burnham Institute for Medical Research |
| Juan Pina-Crespo | research scientist | 2008-2015 | Sanford Burnham Institute |
Collaborators
Sign in to add collaborator| Michael M. Segal | collaborator | 1995-2002 | Children's Hospital and Harvard Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nakamura T, Oh CK, Liao L, et al. (2020) Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease. Science (New York, N.Y.) |
| Ghatak S, Talantova M, Mckercher SR, et al. (2020) Novel Therapeutic Approach for Excitatory/Inhibitory Imbalance in Neurodevelopmental and Neurodegenerative Diseases. Annual Review of Pharmacology and Toxicology |
| Ghatak S, Dolatabadi N, Gao R, et al. (2020) NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models. Molecular Psychiatry |
| Ghatak S, Dolatabadi N, Trudler D, et al. (2019) Mechanisms of hyperexcitability in Alzheimer's disease hiPSC-derived neurons and cerebral organoids vs. isogenic control. Elife. 8 |
| Okamoto SI, Prikhodko O, Pina-Crespo J, et al. (2019) NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model. Neurobiology of Disease |
| Trudler D, Lipton SA. (2019) Novel Direct Conversion of Microglia to Neurons. Trends in Molecular Medicine |
| Mann AP, Scodeller P, Hussain S, et al. (2018) Publisher Correction: Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease. Nature Communications. 9: 1070 |
| Ryan T, Bamm VV, Stykel MG, et al. (2018) Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein. Nature Communications. 9: 817 |
| Oh CK, Sultan A, Platzer J, et al. (2017) S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models. Cell Reports. 21: 2171-2182 |
| Tu S, Akhtar MW, Escorihuela RM, et al. (2017) NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism. Nature Communications. 8: 1488 |